BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26352768)

  • 1. Monitoring lymphoma patients after therapy.
    Roschewski M
    Clin Adv Hematol Oncol; 2015 May; 13(5):277-9. PubMed ID: 26352768
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
    Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
    Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and PET in monitoring response in lymphoma.
    Rahmouni A; Luciani A; Itti E
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S106-12. PubMed ID: 16361125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
    Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
    Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of positron emission tomography in in lymphoma diagnosis and treatment].
    Papamichael DC; Pianou NK; Chatzipavlidou V
    Hell J Nucl Med; 2015; 18(2):173-9. PubMed ID: 26187221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of functional imaging in the management of lymphoma.
    Cheson BD
    J Clin Oncol; 2011 May; 29(14):1844-54. PubMed ID: 21482982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of FDG-PET/CT in the management of lymphoma.
    Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
    Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT for therapy response assessment in lymphoma.
    Hutchings M; Barrington SF
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular lymphoma and central nervous system lymphoma involving the hypothalamus: staging and evaluation of response to therapy with F-18 FDG PET/CT.
    Makis W; Novales-Diaz JA; Hickeson M
    Clin Nucl Med; 2010 Dec; 35(12):956-9. PubMed ID: 21206231
    [No Abstract]   [Full Text] [Related]  

  • 10. Can diffusion-weighed whole-body magnetic resonance imaging with body signal suppression play a role in the management of lymphoma patients?
    Minoia C; Maggialetti N; Ferrari C; Brunese L; Rubini G; Guarini A
    J BUON; 2016; 21(1):282-3. PubMed ID: 27061563
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of PET/CT to evaluate response to therapy in lymphoma.
    Zanoni L; Cerci JJ; Fanti S
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The progress of laboratory medicine and diagnostic procedures in lymphoma and its future prospects].
    Okamoto M
    Nihon Rinsho; 2014 Mar; 72(3):391-8. PubMed ID: 24724393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia and lymphoma.
    Guillerman RP; Voss SD; Parker BR
    Radiol Clin North Am; 2011 Jul; 49(4):767-97, vii. PubMed ID: 21807173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic medical radiation exposure in surveillance of aggressive lymphoma: clinical trial design should reflect clinical practice.
    Hawkes EA; Chong G; Grigg A
    J Clin Oncol; 2015 Apr; 33(10):1219-20. PubMed ID: 25691672
    [No Abstract]   [Full Text] [Related]  

  • 15. PET/CT, MR, and PET/MR in Lymphoma and Melanoma.
    Schwenzer NF; Pfannenberg AC
    Semin Nucl Med; 2015 Jul; 45(4):322-31. PubMed ID: 26050659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place of positron emission tomography imaging in the management of patients with malignant lymphoma.
    Jerusalem G; Beguin Y
    Haematologica; 2006 Apr; 91(4):442-4. PubMed ID: 16585010
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of PET imaging in patients with lymphoma].
    Klaeser B; Krause T
    Ther Umsch; 2010 Oct; 67(10):505-10. PubMed ID: 20886456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic thyroid carcinoma, thyroid lymphoma, and metastasis to thyroid.
    Untch BR; Olson JA
    Surg Oncol Clin N Am; 2006 Jul; 15(3):661-79, x. PubMed ID: 16882503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
    Podoloff DA; Advani RH; Allred C; Benson AB; Brown E; Burstein HJ; Carlson RW; Coleman RE; Czuczman MS; Delbeke D; Edge SB; Ettinger DS; Grannis FW; Hillner BE; Hoffman JM; Kiel K; Komaki R; Larson SM; Mankoff DA; Rosenzweig KE; Skibber JM; Yahalom J; Yu JM; Zelenetz AD
    J Natl Compr Canc Netw; 2007 May; 5 Suppl 1():S1-22; quiz S23-2. PubMed ID: 17509259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical diagnostic imaging (including FDG-PET/CT)].
    Torizuka T
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():198-201. PubMed ID: 23133952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.